Humanistic Care Nursing Mode for Severe Hyperbilirubinemia Patients Who Undergoing Double Plasma Molecular Adsorption System and Plasma Exchange
American Journal of Nursing Science
Volume 9, Issue 3, June 2020, Pages: 116-119
Received: Mar. 26, 2020;
Accepted: Apr. 14, 2020;
Published: Apr. 23, 2020
Views 138 Downloads 50
Rou Wen, Artificial Liver Blood Purification Department, The First Affiliated Hospital of Jinan University, Guangzhou, China
Zhaolin Chen, Digestive Department, The First Affiliated Hospital of Jinan University, Guangzhou, China
Yanyun Chen, Artificial Liver Blood Purification Department, The First Affiliated Hospital of Jinan University, Guangzhou, China
Objective: To assess humanistic care nursing mode for severe hyperbilirubinemia patients who undergoing double plasma molecular adsorption system and plasma exchange. Methods: 124 participants were diagnosed with severe hyperbilirubinemia and were received combined treatment, include that double plasma molecular adsorption system and Plasma exchange. They were randomly assigned to control group (n = 62) and intervention group (n = 62). We collect the participant information by Self-Rating Anxiety Scale, Self-rating depression scale and the Short Form-36. The information include the satisfaction of patients, anxiety status, depression status and quality of life. Result: In patient satisfaction research, the intervention group has more very good level assessment than that of control group (41 vs 32). Also, control group has more good level assessment than that of intervention group (18 vs 8). In anxiety and depression research, intervention group has better improvement in anxiety status, it is from 56.4±6.7 to 45.3±5.1. In quality of life research, the intervention group has greater improvement than that of control group in every domain. Conclusion: humanistic care nursing mode provide better improvement in mental health aspect of patient. It significantly improved anxiety and depression, and improved overall quality of life after treatment.
Humanistic Care Nursing Mode for Severe Hyperbilirubinemia Patients Who Undergoing Double Plasma Molecular Adsorption System and Plasma Exchange, American Journal of Nursing Science.
Vol. 9, No. 3,
2020, pp. 116-119.
Shang J, Jia BL, Zhang HP, Chen P, Jin X. Effects of artificial liver support system on chronic sever hepatitis patients. Zhon-ghua Ganzangbing Zazhi. 2015; 11: 506.
Fawaz R, Baumann U, Ekong U, Fischler B, Hadzic N, Mack CL, Karpen SJ. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for pediatric gastroenterology, hepatology, and nutrition and the european society for pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2017; 64 (1): 154–168.
Moyer V, Freese DK, Whitington PF, Olson AD, Brewer F, Colletti RB. North American Society for Pediatric Gastroenterology, H. p. a. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2016; 39 (2): 115–128 N.
Rangel S, Calkins C, Cowles R, Barnhart D, Huang E, Abdullah F, Teitelbaum D. Parenteral nutrition–associated cholestasis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. 2017; 47 (1): 225–240.
Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics. 2018; 121: e170e9.
Maisels MJ, Deridder JM, Kring EA, Balasubramaniam M. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. J Perinatol 2019; 29: 612e7.
Duan ZJ, Li LL, Ju J, Gao ZH, He GH. Treatment of hyperbilirubinemia with blood purification in China. World J Gastroenterol. 2016; 12 (46): 7467–7471.
Weinshenker BG, O'Brien PC, Petterson TM, et al. A randomised trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 2017; 46 (6): 878–86.
Bramlage CP, Schroder K, Bramlage P, et al. Predictors of complications in plasma exchange. J Clin Apheresis 2018; 24 (6): 225–31.
Yao J, Li S, Zhou Li, Luo L, Yuan L, Duan Z, Xu J, Chen Y. Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure.[J]. Journal of clinical apheresis, 2019, 34 (4).
White D, Leach C, Sims R, Atkinson M, Cottrell D. Validation of the Hospital Anxiety and Depression Scale for use with adolescents. Br J Psychiatry 1999; 175: 452–454.
El-Rufaie O, Absood G. Validity study of the Hospital Anxiety and Depression Scale among a group of Saudi patients. Br J Psychiatry 1987; 151: 687–688.
Ware JE. SF-36 health survey update. Spine. 2000, 25, 3130–3139.
Lehmann HC, Hartung HP, Hetzel GR, Stuve O, Kieseier BC. Plasma exchange in neuroimmunological disorders - Part 1: rationale and treatment of inflammatory central nervous system disorders, Arch. Neurol. 2017; 63 (7): 930–935.
Lankford KV, Grindon AJ, Lyles RH, Hillyer CD. Indications far plasma exchange at a university hospital and a regional blood center, J. Clin. Apher. 2016; 15 (4): 242–248.
Click B, Ketchum AM, Turner R, Whitcomb DC, Papachristou GI, Yadav D. The role of apheresis in hypertriglyceridemia-induced acute pancreatitis: a systematic review. Pancreatology 2015; 15: 313–20.
Lozano M, et al. Apheresis activity in Spain: a survey of the Spanish Apheresis Group. Transfus Apher Sci 2018; 49: 560–564.
Silveira MG, Selva-O'Callaghan A, Ramos-Terrades N, Arredondo-Agudelo KV, Labrador-Horrillo M, Bravo-Masgoret C. Anti-MDA5 dermatomyositis and progressive interstitial pneumonia, QJM: Mon. J. Assoc. Phys. 2016; 109 (1): 49–50.